Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

Details for Australian Patent Application No. 2011217964 (hide)

Owner The Board of Regents of the University of Oklahoma

Inventors Ma, Jian-Xing; Lee, Kyungwon; Chen, Ying

Agent Griffith Hack

Pub. Number AU-A-2011217964

PCT Pub. Number WO2011/103426

Priority 61/306,083 19.02.10 US

Filing date 18 February 2011

Wipo publication date 25 August 2011

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/103426 Priority application(s): WO2011/103426

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217974-System and method to increase the overall diameter of veins

2011217961-Cyclobutane and methylcyclobutane derivatives as Janus kinase inhibitors